Advocating for safe, regulated access to ibogaine therapy in Kentucky — a clinically promising treatment at the forefront of the psychedelic medicine revolution.
The Kentucky Ibogaine Association is a nonprofit advocacy and education organization dedicated to expanding access to ibogaine-assisted therapy for Kentuckians battling addiction, PTSD, and treatment-resistant mental health conditions.
We bridge the gap between emerging psychedelic medicine research and the communities who need it most — working with legislators, clinicians, researchers, and survivors to build a regulatory framework that prioritizes safety, equity, and healing.
Ibogaine is a naturally occurring psychoactive alkaloid derived from the root bark of the Tabernanthe iboga plant, native to Central Africa. Used for centuries in the Bwiti spiritual tradition of Gabon, it has emerged as one of the most compelling — and clinically studied — candidates in the psychedelic medicine renaissance.
Kentucky consistently ranks among the top states for drug overdose mortality. The opioid epidemic has devastated communities across the Commonwealth — from Appalachia to Louisville — leaving families shattered and traditional treatment options falling short.
Conventional addiction treatment has a relapse rate exceeding 70%. We need every tool available. Ibogaine represents a fundamentally different approach — one that has given hope to thousands of Kentuckians forced to travel to Mexico, Canada, or Europe for access.
"The science is clear. The urgency is undeniable. Kentucky deserves access to treatments that work — and ibogaine is among the most promising we have ever seen."
Three ways to help us build a future where every Kentuckian has access to the healing they deserve.